<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 26, 1998
MEDIRISK, INC.
(Exact name of registrant
as specified in its charter)
<TABLE>
<CAPTION>
Delaware 000-22005 58-2256400
------------------------------------------------------------------------------
<S> <C> <C>
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification No.)
incorporation)
Two Piedmont Center, Suite 400, 3565 Piedmont Road, N.E., Atlanta, Georgia 30305
- ---------------------------------------------------------------------------------------------
(Address of principal executive officers) (Zip Code)
</TABLE>
Registrant's telephone number, including area code: (404) 364-6700
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE> 2
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.
On June 26, 1998, Medirisk, Inc. (the "Company") acquired all of the
capital stock of Sweetwater Health Enterprises, Inc., a Texas corporation
("Sweetwater Health"), for approximately $6.2 million in cash (the
"Acquisition"). The Acquisition was made pursuant to a Stock Purchase Agreement
dated as of June 25, 1998 by and among the Company and the shareholders of
Sweetwater Health (the "Purchase Agreement"). The Company used a portion of the
proceeds of its recently completed offering of Common Stock to finance the
acquisition.
Sweetwater Health also entered into Employment Agreements with two
senior executives of Sweetwater Health. The purchase price and other terms of
the Acquisition were determined as a result of arms' length negotiations between
unrelated parties. At the closing date, there was no material relationship
between the Company and Sweetwater Health or any of the shareholders of
Sweetwater Health, or any of their respective affiliates, officers, directors or
associates.
Sweetwater Health, based in Dallas, Texas, provides physician
credentialing services, quality management software and managed care consulting
to healthcare payors and providers. Sweetwater Health offers a comprehensive
selection of physician credentialing services to hospitals and managed care
organizations to evaluate professional relationships with physicians and secure
accreditation by industry associations. In addition, Sweetwater Health provides
a suite of quality management software used by healthcare organizations to
facilitate in-house credentialing and network management, as well as to track
perceptions of care and individual physician performance. Additional offerings
include managed care consultation and interim management services for healthcare
organizations throughout the country.
ITEM 5. OTHER EVENTS.
On June 30, 1998, the Company issued a press release announcing that
second quarter revenues and adjusted earnings per share will be less than
expected. Based on a preliminary analysis of results for the second quarter
ending June 30, 1998, revenues are expected to be in the range of $5.1 million
to $5.3 million and earnings per share, adjusted to exclude one-time
non-recurring charges, are expected to be in the range of $0.00 to $0.02 per
share; however, no assurance can be given as to actual results. The Company
reported revenues of $3.2 million and adjusted earnings per share of $0.07 per
share in the second quarter of 1997.
On June 29, 1998, the Company and NationsBank, N.A. entered into an
Amended and Restated Credit Agreement under which the maximum amount available
under the Company's revolving line of credit was increased from $10.0 million to
$25.0 million. In addition to the increase in availability, the Amended and
Restated Credit Agreement also extends the maturity of the credit facility to
July 15, 2000 and lowers the interest rates payable on LIBOR borrowings.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) FINANCIAL STATEMENTS OF BUSINESS ACQUIRED.
It is impractical to provide financial statements for Sweetwater
Health, to the extent required, at the date of the filing of this Form 8-K. The
financial statements, if required, will be provided as soon as practicable but
not later than 60 days after the date on which this Form 8-K is filed.
2
<PAGE> 3
(b) PRO FORMA FINANCIAL INFORMATION.
It is impractical to file the pro forma financial information for
Sweetwater Health, to the extent required, at the date of the filing of this
Form 8-K. The pro forma financial information, if required, will be provided as
soon as practicable, but not later than 60 days after the date on which this
Form 8-K is filed.
(c) EXHIBITS.
2.8 Stock Purchase Agreement, dated as of June 25, 1998, by and
among Medirisk, Inc., VHA Southwest, Inc., Marsha L. Ballard
and Robert P. French. In accordance with Item 601(b)(2) of
Regulation S-K, the Exhibits and Schedules to the Stock
Purchase Agreement have not been filed as exhibits to this
Form 8-K. The Registrant agrees to furnish supplementally a
copy of the omitted Exhibits and Schedules upon request.
99.1 Press Release issued June 30, 1998, regarding the matters
discussed in this Form 8-K.
3
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDIRISK, INC.
By: /s/ Kenneth M. Goins, Jr.
--------------------------------
Kenneth M. Goins, Jr.
Executive Vice President and
Chief Financial Officer
Dated: June 30, 1998
4
<PAGE> 5
EXHIBIT INDEX
<TABLE>
<CAPTION>
PAGE
----
<S> <C> <C>
2.8 Stock Purchase Agreement, dated June 25, 1998, by and among
Medirisk, Inc., VHA Southwest, Inc., Marsha L. Ballard, and
Robert P. French.
99.1 Press Release, dated June 30, 1998, regarding the matters
discussed in this Form 8-K.
</TABLE>
<PAGE> 1
STOCK PURCHASE AGREEMENT
THIS STOCK PURCHASE AGREEMENT (this "Agreement"), is made this 25th day
of June 1998, by and among MEDIRISK, INC., a Delaware corporation (the
"Purchaser"), MARSHA L. BALLARD, a resident of the State of Texas ("Ballard"),
ROBERT P. FRENCH, a resident of the State of Texas ("French"), and VHA
SOUTHWEST, INC., a Texas corporation ("VHA;" Ballard, French and VHA being
hereinafter collectively referred to as the "Shareholders" and individually as a
"Shareholder," and Ballard and French being sometimes hereinafter collectively
referred to as the "Responsible Shareholders");
W I T N E S S E T H:
WHEREAS, the parties desire to enter into this Stock Purchase Agreement
pursuant to which Purchaser will purchase all of the outstanding capital stock
of Sweetwater Health Enterprises, Inc., a Texas corporation (the "Company") from
the Shareholders upon the terms and subject to the conditions set forth herein
(such purchase being sometimes hereinafter referred to as the "Acquisition");
and
WHEREAS, Ballard and French are employees, officers and/or directors of
the Company, and will receive appreciable benefits from the purchase and sale of
the stock of the Company as contemplated hereby;
NOW, THEREFORE, in consideration of the premises and the mutual
promises, representations, warranties and covenants hereinafter set forth, the
parties hereto agree as follows:
ARTICLE I
PURCHASE AND SALE OF COMPANY STOCK
1.1 PURCHASE AND SALE OF COMPANY STOCK. Subject to the terms and
conditions hereinafter set forth, the Shareholders shall sell to Purchaser, and
Purchaser shall purchase from the Shareholders, free and clear of all liens,
claims, charges and encumbrances of any nature whatsoever, an aggregate of
300,000 shares of issued and outstanding common stock of the Company
(collectively, the "Company Stock"), which shares represent all issued and
outstanding shares of capital stock of the Company. Each Shareholder shall sell
the number of shares of Company Stock set forth opposite his, her or its name on
SCHEDULE 1.1.
1.2 PURCHASE PRICE. In consideration of the sale and delivery of the
Company Stock, and in reliance on the representations and warranties set forth
in Article II below, Purchaser shall pay to the Shareholders the sum of
$6,207,508.00 in the aggregate in cash by
<PAGE> 2
wire transfer at Closing, such amount to be allocated among the Shareholders as
set forth on SCHEDULE 1.2 under the heading of "Allocation of Purchase
Consideration to Shareholders." (Such consideration being hereinafter referred
to as the "Purchase Consideration.")
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE SHAREHOLDERS
The Responsible Shareholders, jointly and severally, represent and
warrant to Purchaser as follows (with all Shareholders severally, but not
jointly and severally, making the representations and warranties set forth in
Sections 2.2 and 2.3(b) below):
2.1 ORGANIZATION AND STANDING. The Company is a corporation duly
organized, validly existing and in good standing under the laws of the State of
Texas with the full power and authority to carry on its business in the places
and as it is now being conducted and to own and lease the properties and assets
it now owns or leases. The Company is duly qualified to transact business and in
good standing in the other states listed on SCHEDULE 2.1, which, except for
immaterial failures to qualify, are the only additional jurisdictions in which
operations of the Company's business or the assets of the Company require such
qualification.
2.2 AUTHORITY AND STATUS. Each Shareholder has the capacity and
authority to execute and deliver this Agreement, to perform its respective
obligations hereunder and to consummate the transactions contemplated by this
Agreement without the necessity of any act or consent of any other person not
previously obtained. This Agreement and each and every agreement, document and
instrument to be executed, delivered and performed in connection with this
Agreement (the "Transaction Documents") by each Shareholder constitute or will,
when executed and delivered, constitute the valid and legally binding
obligations of such Shareholder, enforceable against such Shareholder in
accordance with their respective terms, except as enforceability may be limited
by applicable equitable principles (whether applied with action at law or in
equity) or by bankruptcy, insolvency, reorganization, moratorium or similar laws
from time to time in effect affecting the enforcement of creditors' rights
generally.
2.3 CAPITALIZATION; OWNERSHIP OF COMPANY STOCK.
(A) The authorized capital stock of the Company consists of
1,000,000 shares of Class A common stock, $0.01 par value per share, 285,000 of
which are issued and outstanding, 100,000 shares of Class B common stock, $0.01
par value per share, 15,000 of which are issued and outstanding, and 100,000
shares of Class C common stock, $0.01 par value per share, none of which are
issued or outstanding (collectively, the "Company Stock"). All of the issued and
outstanding shares of Company Stock are duly and validly issued and outstanding,
are fully paid and nonassessable, and were issued pursuant to a valid exemption
from registration under the Securities Act of 1933, as amended (the "Securities
Act"), and in accordance in all material respects with all applicable state
securities laws. Except as set forth on SCHEDULE 2.3, there are no outstanding
warrants, options, rights, calls or other commitments of any nature
-2-
<PAGE> 3
relating to the common stock or any other capital stock of the Company, and
there are no outstanding securities of the Company convertible into or
exchangeable for shares of common stock or any other capital stock of the
Company.
(B) Each Shareholder is the legal and beneficial owner of the
number of shares of Company Stock reflected opposite his, her or its name on
SCHEDULE 1.1, free and clear of all liens, claims, charges, encumbrances,
security interests, pledges or other claims.
2.4 SUBSIDIARIES, INVESTMENTS AND PREDECESSORS. Except as set forth on
SCHEDULE 2.4, the Company has not owned and does not currently own, directly or
indirectly, of record, beneficially or equitably any capital stock or other
equity, ownership or proprietary interest in any corporation, partnership,
limited liability company, association, trust, joint venture or other entity.
Set forth on SCHEDULE 2.4 is a listing for the last five years of all
predecessor companies of the Company, including the names of any and all
entities from which the Company previously acquired material assets, and any
other entity of which the Company has been a subsidiary or division. Except as
listed on SCHEDULE 2.4, the Company has not sold or disposed of, by way of asset
sale, stock sale, spin-off, split-up or otherwise, any material assets or
business of the Company.
2.5 LIABILITIES AND OBLIGATIONS OF THE COMPANY.
(A) Attached as SCHEDULE 2.5 are true, correct and complete
copies of the Company's audited balance sheets as of 31 December 1995, 1996 and
1997 and the related statements of operations and cash flows for the fiscal
years ending on 31 December 1995, 1996 and 1997 (together with the notes
thereto, the "Financial Statements"). Also attached as SCHEDULE 2.5 are true,
correct and complete copies of the Company's unaudited balance sheet as of 31
May 1998 and the related unaudited statement of operations for the five-month
period then ended (the "Interim Financial Statements"). Except as specifically
described in SCHEDULE 2.5, the Financial Statements are complete to the extent
required by generally accepted accounting principles, and the Financial
Statements and the Interim Financial Statements have been prepared in accordance
with generally accepted accounting principles (except that the Interim Financial
Statements do not contain any notes thereto and are subject to normal recurring
year-end adjustments, which individually and in the aggregate will not deviate
substantially therefrom). Subject to the foregoing sentence, the Financial
Statements and the Interim Financial Statements fairly present in accordance
with generally accepted accounting principles the financial condition of the
Company and the results of its operations and changes in financial position in
all material respects as of the dates and for the periods reflected therein.
(B) Except as described in SCHEDULE 2.5, the Company has no
liability or obligation related to its assets or business (whether accrued,
absolute, contingent or otherwise), except for (i) the liabilities and
obligations of the Company that are disclosed or reserved against in the Interim
Financial Statements or disclosed in the notes to the Financial Statements as of
and for the period ended 31 December 1997, to the extent and in the amounts so
disclosed or reserved against, (ii) liabilities that were incurred or accrued in
the ordinary course of the Company's business since the date of the Interim
Financial Statements, (iii) the liabilities and obligations of
-3-
<PAGE> 4
the Company under the Material Agreements (as that term is defined in Section
2.11), and (iv) liabilities and obligations of the Company which, individually
or in the aggregate, do not, and which are reasonably not expected to, exceed
$50,000.00. For purposes of this Agreement and the Schedules hereto, the parties
acknowledge that liabilities of the Company disclosed on the Financial
Statements or Interim Financial Statements which do not attach to any specific
asset of the Company do not need to be specifically referenced in this Agreement
nor disclosed on any Schedule hereto as an exception to title or otherwise.
2.6 AGREEMENT DOES NOT VIOLATE OTHER INSTRUMENTS. Except as set forth
on SCHEDULE 2.6, the execution and delivery of the Transaction Documents by each
of the Shareholders do not, and the consummation of the transactions
contemplated hereby will not, (a) violate or conflict with any provision of the
Articles of Incorporation, as amended, or Bylaws, as amended, of the Company;
(b) require any consent or approval not previously obtained under, conflict
with, result in the breach, termination or acceleration of, or violate or
constitute an occurrence of default under any provision of any mortgage, deed of
trust, conveyance to secure debt, note, loan, lien, lease, agreement or
instrument to which the Company is a party or by which any of the Company's
properties are bound; (c) constitute a violation of any law, regulation, order,
writ, judgment, injunction, or decree applicable to the Company or by which any
of the Company's properties are bound; (d) result in the creation of any lien
upon any of the assets or business of the Company, other than liens granted by
Purchaser; or (e) to the reasonable knowledge and belief of the Responsible
Shareholders, have any material impact on Purchaser's right after the Closing to
conduct the business of the Company as being conducted by the Company prior to
the Closing.
2.7 LITIGATION Except as set forth on SCHEDULE 2.7, there is no suit,
action, proceeding, claim or investigation pending or, to the knowledge of the
Responsible Shareholders, threatened against the Company; and to the knowledge
of the Responsible Shareholders, there exists no basis or grounds for any such
suit, action, proceedings, claim or investigation that, individually or in the
aggregate, would reasonably be expected to have a material adverse impact upon
the transactions contemplated hereby or the business or financial condition of
the Company. SCHEDULE 2.7 also contains a brief description of (a) any suit,
action, legal proceeding or claim involving the Company settled or otherwise
concluded since 1 January 1993, or (ii) any investigation by a governmental
agency which to the knowledge of the Responsible Shareholders involved the
Company and which has been settled or otherwise concluded since 1 January 1993.
2.8 PERMITS. Except as set forth on SCHEDULE 2.8, the Company holds all
licenses, permits and other authorizations from all appropriate federal, state
or other public authorities which are material to the Company's business and
which are legally required for the conduct of the Company's business and the use
of its assets, all of which are listed on SCHEDULE 2.8. Except as set forth on
SCHEDULE 2.8, the Company is conducting and has conducted its business so as to
comply with all applicable statutes, rules, ordinances, regulations, orders,
injunctions, decrees or any other requirement of any governmental body, agency
or authority binding on it, or relating to its property or business or its
advertising, sales or pricing practices ("Applicable Law") except where the
failure to comply with such Applicable Law would not have a material adverse
affect on the Company, its properties, operations or financial condition.
-4-
<PAGE> 5
2.9 TITLE TO ASSETS. Attached as SCHEDULE 2.9 is a list and summary
description of all real property owned or leased by the Company and of all items
of personal property with a fair market value in excess of $15,000.00 owned or
leased by the Company (such list identifying the properties owned by the Company
and all of the leases or agreements under which the Company is lessee of or
holds or operates any property within the specified parameters). Except as set
forth on SCHEDULE 2.9, the Company has good and valid title to all of its
property and assets, other than leased property, free and clear of any liens,
claims, charges, options, rights of tenants or other encumbrances, except (a) as
disclosed or reserved in the Financial Statements or the Interim Financial
Statements and (b) for liens for current taxes not yet due and payable, and (c)
liens or other encumbrances securing amounts payable (not exceeding $25,000.00
in the aggregate) to materialmen, carriers, landlords and like persons, all of
which may not yet be due and payable.
2.10 COMPUTER SOFTWARE, INTELLECTUAL PROPERTY.
(A) Attached SCHEDULE 2.10(A) sets forth a list and summary
description, complete and correct in all material respects, of all trademarks,
trade names, service marks, service names, brand names, copyrights and patents,
registrations thereof and applications therefor, applicable to or used by the
Company in the conduct of its business, together with a complete list of all
licenses granted by or to the Company with respect to any of the above. All such
trademarks, trade names, service marks, service names, brand names, copyrights
and patents reflected on SCHEDULE 2.10(A) as owned by the Company are owned by
the Company free and clear of all liens, claims, security interests and
encumbrances of any nature whatsoever. All such trademarks, trade names, service
marks, service names, brand names, copyrights and patents reflected on SCHEDULE
2.10(A) as licensed, leased or otherwise used (but not owned) by the Company are
used by the Company pursuant to terms of binding agreements under which the
Company has the right to use such trademarks, trade names, service marks,
service names, brand names, copyrights and patents as currently used in the
Company's business without payment of any royalty or other fee, except as set
forth on SCHEDULE 2.10(A). The Company is not currently in receipt of any notice
of violation of, and the Company is not violating, the rights of others in any
trademark, trade name, service mark, copyright, patent, trade secret, know-how
or other intangible asset.
(B) Attached SCHEDULE 2.10(B) contains a list, complete and
correct in all material respects, of the computer software, databases and other
intellectual property that is owned by the Company (the "Owned Software").
Except as set forth on SCHEDULE 2.10(B), the Company has exclusive rights and
title to the Owned Software, free and clear of all liens, claims, security
interests and encumbrances of any nature whatsoever, including claims or rights
of employees, agents, consultants, customers, licensees or other parties
involved in the development, creation, marketing, maintenance, enhancement or
licensing of such Owned Software. Except as set forth on SCHEDULE 2.10(B), the
Owned Software is not dependent on any Licensed Software (as defined below) in
order to operate fully in the manner in which it currently is operated, except
for operating systems and third party applications that are stated in the Owned
Software documentation and are readily commercially available. No Owned Software
has been
-5-
<PAGE> 6
published or disclosed by the Company to any other parties, except as
set forth on SCHEDULE 2.10(B) and except pursuant to contracts requiring such
other parties to keep such Owned Software confidential. To the knowledge of the
Responsible Shareholders, no such other party has breached any such obligation
of confidentiality.
(C) Attached SCHEDULE 2.10(C) contains a list, complete and
correct in all material respects, of all computer software, databases and other
intellectual property that is used by the Company and for which the Company is
the licensee or lessee or otherwise has legal rights of use (other than
commercially available over-the-counter "shrinkwrap" software) (the "Licensed
Software"). SCHEDULE 2.10(C) also sets forth a list, complete and correct in all
material respects, of all license fees, rents, royalties or other charges that
the Company is required or obligated to pay with respect to Licensed Software.
Prior to the date of this Agreement, the Company has delivered to Purchaser true
and complete copies of all agreements under which the Company has the right to
use Licensed Software. Except as described on SCHEDULE 2.10(C), the Company has
the right and license to use, sublicense, modify and copy the Licensed Software,
free and clear of any limitations or encumbrances other than the payment of
license or royalty fees set forth on SCHEDULE 2.10(C). The Company is in
compliance in all material respects with all provisions of any license, lease or
other similar agreement pursuant to which the Company has rights to use the
Licensed Software. Except as disclosed on SCHEDULE 2.10(C), none of the Licensed
Software has been incorporated into or made a part of any Owned Software or any
other Licensed Software. The Company has not published or disclosed any Licensed
Software to any other party except, in the case of Licensed Software that the
Company leases or markets to others, in accordance with and as permitted by any
license, lease or similar agreement relating to the Licensed Software and except
pursuant to contracts requiring such other parties to keep the Licensed Software
confidential. To the knowledge of the Responsible Shareholders, no party to whom
the Company has disclosed Licensed Software has breached such obligation of
confidentiality.
(D) The Owned Software and the Licensed Software constitute
all software used by the Company in relation to the business of the Company (the
"Company Software"). Attached SCHEDULE 2.10(D) sets forth a list of all contract
programmers, independent contractors, nonemployee agents and persons or other
entities (other than employees) who have performed computer programming services
for the Company in connection with any of the Owned Software and identifies all
contracts and agreements to which the Company is a party pursuant to which such
services were performed. The transactions contemplated by this Agreement will
not cause a breach or default under any license or similar agreement relating to
the Company Software or materially impair the Company's ability to use the
Company Software in the same manner as such Company Software is currently used
by the Company. The Company is not infringing any intellectual property rights
of any other person or entity with respect to the Company Software, and, to the
knowledge of the Responsible Shareholders, no other person or entity is
infringing any intellectual property rights of the Company with respect to the
Company Software.
(E) The Company and, to the knowledge of the Responsible
Shareholders, all other parties to any licensing or similar arrangements under
which the Company is the licensor or has otherwise granted the right to use the
Company Software are in compliance in all material
-6-
<PAGE> 7
respects with such licensing or similar arrangements and are not in breach in
any material respect of their obligations with respect thereto. The Company is
not a party to any license, installation agreement, maintenance agreement, data
processing agreement, services agreement or other agreement pursuant to which it
is committed to perform software installation, modifications, enhancements or
services without payment or for payments which, in the aggregate, are less than
the reasonably anticipated cost to perform such installation, modifications,
enhancements or services. The Company has complied in all material respects with
its obligations to its customers and licensees in respect of the Company
Software.
(F) Except as set forth on SCHEDULE 2.10(F), the Company has
granted no marketing rights in the Company Software to any third party, and, to
the knowledge of the Responsible Shareholders, all marketing rights granted by
any third party to the Company for such third-party's software, if any, have
been granted exclusively to the Company. SCHEDULE 2.10(F) lists and separately
identifies all agreements pursuant to which the Company has granted or been
granted rights to market software, databases and other intellectual property
owned by third parties.
2.11 CONTRACTS.
(A) Attached as SCHEDULE 2.11(A) is a true and correct list of
all contracts, agreements and other instruments to which the Company is a party
(other than contracts with the customers of the Company for provision of the
Company's products or services) under which the aggregate liability of, or
benefit to, the Company under any such contract, agreement or other instrument
could reasonably be expected to exceed $15,000.00, and including without
limitation as to value (but except as otherwise hereinafter provided), all
contracts, agreements and other instruments concerning the following matters
(collectively the "Material Agreements"):
(i) the lease (as lessee or lessor) or license (as licensee or
licensor) of (A) any personal property (tangible or intangible) having an
aggregate liability or benefit to the Company in excess of $15,000.00, or (B)
any real property;
(ii) the employment, termination, severance or engagement
of or with respect to any officer, director, employee, consultant or agent;
(iii) any arrangement between or among the Company, its
affiliates, the Shareholders, any director, officer or employee thereof and/or
related persons, with respect to loans, guarantees and credit arrangements to or
from such persons;
(iv) any arrangement limiting the freedom of the Company
to compete in any manner in any line of business or requiring the Company to
share profits;
(v) any arrangement that could reasonably be anticipated
to have a material adverse effect on the Company, financial or otherwise;
(vi) any arrangement not in the ordinary course of
business having an aggregate liability or benefit to the Company in excess of
$15,000.00;
-7-
<PAGE> 8
(vii) any power of attorney, whether limited or general,
granted by or to the Company;
(viii) any other arrangement that requires performance for a
period of more than thirty (30) days, other than contracts entered into in the
ordinary course of business;
(ix) any loan agreement, contract or other arrangement
relating to the borrowing of money by the Company and the amount outstanding
thereunder or the guarantee by the Company of any third-party obligation (other
than endorsements of checks in the ordinary course of business);
(x) any agreement or arrangement involving intellectual
property rights, other than (A) contracts entered into in the ordinary course of
business with customers, (B) "shrink-wrap" software licenses and (C) items
listed in SCHEDULES 2.10(A), 2.10(B), 2.10(C) or 2.10(F);
(xi) any contract or arrangement relating to the provision
of data processing or network communication (including telecommunication)
services to or by the Company or any affiliate thereof; and
(xii) any contract or arrangement relating to the
provision, purchase or sale of goods or services, other than (A) contracts
entered into in the ordinary course of business and involving payments not in
excess of $15,000.00, and (B) contracts or arrangements that may be cancelled by
the Company on not more than thirty (30) days' notice without further obligation
by the Company (other than liabilities associated with goods or services
delivered pursuant to such contracts or arrangements).
(B) Except as set forth on SCHEDULE 2.11(B), (i) the Material
Agreements are valid, effective and binding upon the Company and, to the
knowledge of the Responsible Shareholders, binding upon the other parties
thereto, in accordance with their terms, (ii) there is not under any Material
Agreement (A) any existing or claimed material default by the Company or (B) to
the knowledge of the Responsible Shareholders, any existing or claimed material
default by any other party, and (iii) there is no actual or, to the knowledge of
the Responsible Shareholders, threatened, termination, cancellation or
limitation of any Material Agreements (except for scheduled expirations as may
occur pursuant to the express terms of any such Material Agreement). To the
knowledge of the Responsible Shareholders, there is no pending or threatened
bankruptcy, insolvency or similar proceeding with respect to any other party to
any of the Material Agreements.
2.12 TAXES.
(A) Except for immaterial failures to file, the Company has
timely and accurately filed all federal, state, foreign, local and other tax and
information returns and reports required to be filed by it and has timely paid,
or will timely pay, all taxes, including, without limitation, any and all
income, sales, use, withholding, excise and other taxes (collectively "Taxes")
due, owing and payable on or before the Closing Date for all periods prior to
Closing. No liens have been filed and no claims are being asserted or, to the
knowledge of the
-8-
<PAGE> 9
Responsible Shareholders, contemplated with respect to any Taxes owed by the
Company. No restrictions on assessment or collection of Taxes have been waived
with respect to the Company, and the Company has not consented to the extension
of any statute of limitations with respect to the Company relating to Taxes,
except for waivers or consents that are no longer in effect. The Company has
received no notice of assessment or proposed assessment of any Taxes claimed to
be owed by it or any other person or entity on its behalf. Except as set forth
on SCHEDULE 2.12, no returns, reports or forms filed by or on behalf of the
Company with respect to Taxes are currently being audited or examined, and the
Company has not received any notice of any such audit or examination.
(B) The Company has withheld or collected from each payment
made to each of its employees the amount of all Taxes required to be withheld or
collected therefrom, and the Company has, to the extent due, paid the same to
the proper tax depositories or collecting authorities.
(C) All ad valorem property taxes for years prior to 1998
imposed on the Company with respect to, or which may become a lien on, its
assets have been paid in full.
2.13 EMPLOYEE BENEFIT PLANS. Attached as SCHEDULE 2.13 is a list of
every pension, retirement, profit-sharing, deferred compensation, severance pay,
vacation, bonus or other incentive plan, any other written or unwritten employee
program, arrangement, agreement or understanding that involves the expenditure
of more than $1,000.00 per year, any medical, vision, dental or other health
plan, any life insurance plan or any other employee benefit plan or fringe
benefit plan, including without limitation any "employee benefit plan," as that
term is defined in Section 3(3) of the Employee Retirement Security Act of 1974,
as amended ("ERISA"), adopted, maintained, sponsored or contributed to by the
Company at any time during the six-year period ending on the date hereof for the
benefit of employees, retirees, dependents, spouses, directors or other
beneficiaries and under which employees, retirees, dependents, spouses,
directors or other beneficiaries are eligible to participate (collectively, the
"Benefit Plans"). All of the Benefit Plans (and any related trusts subject to
ERISA) comply with and have been administered in all material respects in
compliance with the applicable provisions of ERISA, all applicable provisions of
the Code, all applicable state or federal securities laws and all other
applicable laws, rules and regulations. No event has occurred that will or could
reasonably be expected to give rise to a disqualification of any such plan under
Sections 401(a) or 501(a) of the Code or to a tax under Section 511 of the Code.
Neither the Company nor any administrator or fiduciary of any such Benefit Plan
(or agent or delegate of any of the foregoing) has engaged in any transaction or
acted or failed to act in any manner that could reasonably be expected to
subject the Company to any direct or indirect liability for a breach of any
fiduciary or co-fiduciary duty under ERISA. No "party in interest" (as defined
in Section 3(14) of ERISA) or "disqualified person" (as defined in Section
4975(e)(2) of the Code) of any Benefit Plan has engaged in any "prohibited
transaction" (within the meaning of Section 4975(c) of the Code or Section 406
of ERISA and not exempt under Section 408 of ERISA) for which there is no
applicable exemption.
-9-
<PAGE> 10
2.14 CUSTOMERS. Attached as SCHEDULE 2.14 is a list, complete and
correct in all material respects, of all of the customers doing in excess of
$15,000.000 of business with the Company during 1995 and 1996, and in excess of
$5,000.00 of business in 1997 and to date in 1998 setting forth as to each such
customer its name, address, telephone number and principal person of contact.
The Company has not received any notice, nor does it have any reason to believe,
that any such customer has taken or contemplates taking steps that could disrupt
the business relationship of the Company with such customer.
2.15 OFFICERS, DIRECTORS AND BANK ACCOUNTS. SCHEDULE 2.15(A) lists the
names of all directors and officers of the Company. SCHEDULE 2.15(B) lists the
name and location of each bank or other institution in which the Company has any
deposit account or safe deposit box, all account numbers and names of all
persons authorized to draw thereon or to have access thereto.
-10-
<PAGE> 11
2.16 INTERESTED TRANSACTIONS. Except as set forth on SCHEDULE 2.16, the
Company is not a party to any contract, agreement or other instrument or
transaction with any of the following persons, or in which any of the following
persons have any direct or indirect interest (other than as a shareholder or
employee of the Company):
(A) Any director or officer of the Company or any of the
Shareholders;
(B) Any of the spouses, parents, siblings, children, aunts,
uncles, nieces, nephews, in-laws or grandparents of any of the persons described
in clause (a); or
(C) Any corporation, trust, partnership or other entity in
which any of the persons described in clauses (a) or (b) has a beneficial
interest (other than in a corporation whose shares are publicly traded and in
which such persons own beneficially in the aggregate no more than two (2%)
percent of the equity interest).
2.17 ABSENCE OF CERTAIN CHANGES. Since 31 December 1997, and except as
set forth on SCHEDULE 2.17: (a) the Company has operated its business in the
ordinary course; (b) there has not been any change in the business, financial
condition or results of operations of the Company that has had or is reasonably
likely to have a material adverse effect on the Company or its assets or
business; (c) there has not been any damage, destruction or loss (whether or not
covered by insurance) to the Company's assets that has had or is reasonably
likely to have a material adverse effect on the Company or its assets or
business; (d) except as disclosed in SCHEDULE 2.17, no customer has canceled or
given written or oral notice of its intention to cancel, discontinue or
substantially reduce its business with the Company; and (e) except as disclosed
in SCHEDULE 2.17, the Company is not in default in any material respect and, to
the knowledge of the Responsible Shareholders, no customer is in default in any
material respect, under the Company's contracts with any customer, and each such
contract is in full force and effect on the date of this Agreement, and such
customer contracts contain no material changes from the standard form of
agreement used by the Company (including, without limitation, any deviation from
the standard warranties or limitation of the Company's liability).
2.18 BOOKS AND RECORDS. Subject to the qualifications set forth in this
Agreement, all books, records and other information (financial and otherwise),
if any, provided by the Company or any Shareholder to Purchaser are true and
correct and accurately reflect the existence of the Company's assets and the
results of operations of the Company's business for the periods of time stated
therein, and such books, records and financial information reflect revenues and
income from the Company's business and not from other sources, except as
expressly disclosed to Purchaser.
2.19 ACCOUNTS RECEIVABLE AND PAYABLE. The accounts receivable
outstanding as of the date of the Interim Financial Statements are, and the
accounts receivable of the Company outstanding as of the Closing Date will be,
(a) valid and genuine accounts receivable arising only out of bona fide sales
and delivery of goods, performance of services and other business transactions
in the ordinary course of the Company's business consistent with past practice;
(b) subject to no asserted defenses, counterclaims or rights of setoff, and (c)
except as set forth on
-11-
<PAGE> 12
SCHEDULE 2.19, collectible within sixty (60) days after billing at the full
recorded amount thereof less the recorded allowance for doubtful accounts
reflected on the Interim Financial Statements. Except as set forth on SCHEDULE
2.19, no accounts payable of the Company are, as of the date of this Agreement,
over sixty (60) days old.
2.20 EMPLOYMENT AND LABOR MATTERS.
(A) SCHEDULE 2.20(A) sets forth (i) the number of all
full-time and part-time employees of the Company; (ii) the number of independent
contractors utilized by the Company and (iii) the name and compensation paid to
each independent contractor, employee of or consultant to the Company who
received salary, bonuses or other compensation for either of the Company's two
most recently ended fiscal years in excess of $35,000.00.
(B) To the knowledge of the Responsible Shareholders, the
Company is in compliance in all material respects with all applicable laws
respecting employment and employment practices, terms and conditions of
employment, wages and hours, occupational safety and health, including laws
concerning unfair labor practices within the meaning of Section 8 of the
National Labor Relations Act, and the employment of non-residents under the
Immigration Reform and Control Act of 1986.
(C) Except as disclosed on SCHEDULE 2.20(C):
(i) There are no charges, governmental audits,
investigations, administrative proceedings or complaints concerning the
Company's employment practices pending or, to the knowledge of the Responsible
Shareholders, threatened before any federal, state or local agency or court,
and, to the knowledge of the Responsible Shareholders, no basis for any such
matter exists;
(ii) The Company is not a party to any union or
collective bargaining agreement, and, to the knowledge of the Responsible
Shareholders, no union attempts to organize the employees of the Company have
been made, and no such attempts are now threatened; and
(iii) The Company has not experienced any organized
slowdown, work interruption, strike, or work stoppage by its employees.
2.21 INSURANCE. Except as described on SCHEDULE 2.21, all of the assets
and business of the Company are insured in such amounts and against such losses,
casualties or risks as are customary for similar properties and businesses, and
SCHEDULE 2.21 contains a list of all policies of insurance currently in force
with respect to the Company and its assets and business.
2.22 ENVIRONMENTAL MATTERS. To the knowledge of the Responsible
Shareholders and except as set forth in SCHEDULE 2.22, there is no present or
past Environmental Condition in any way relating to the business, properties or
assets of the Company. "Environmental
-12-
<PAGE> 13
Condition" means (a) the introduction into the environment of any pollution,
including without limitation any contaminant, irritant or pollutant or other
toxic or hazardous substance, in violation of any federal, state or local law,
ordinance or governmental rule or regulations, as a result of any spill,
discharge, leak, emission, escape, injection, dumping or release of any kind
whatsoever of any substance or exposure of any type in any workplaces or to any
medium, including without limitation air, land, surface waters or ground waters,
or from any generation, transportation, treatment, discharge, storage or
disposal of waste materials, raw materials, hazardous materials, biomedical
waste including blood, toxic materials or products of any kind or from the
storage, use or handling of any hazardous or toxic materials or other
substances, as a result of which the Company has or may become liable to any
person or by any reason of which any of the assets of the Company may suffer or
be subjected to any lien, encumbrance or restriction of any nature, or (b) any
noncompliance with any federal, state or local environmental law, rule,
regulation or order as a result of or in connection with any of the foregoing.
2.23 COMPANY PRODUCTS AND SERVICES. The Company's products and services
conform in all material respects with any specification, documentation,
performance standard, representation or statement made or provided with respect
thereto by or on behalf of the Company, and there has not been during the last
three (3) years any claim made against the Company by any customer of the
Company or by any other person alleging that any product or service of the
Company (including each version thereof that has been licensed or otherwise made
available by the Company to any person) does not conform in all material
respects with any specification, documentation, performance standard,
representation or statement made or provided by or on behalf of the Company,
and, to the knowledge of the Responsible Shareholders, there is not a reasonable
basis for any such claim. No material product liability or warranty claims have
been communicated in writing to or threatened in writing against the Company. To
the knowledge of the Responsible Shareholders, the Company's products and
services, as of the date hereof, during and after the calendar year 2000 A.D.,
include design, function and performance capabilities such that the Company's
products and services shall not abnormally end and/or have invalid and/or
incorrect results from and/or performance or functional degradation because of
the then-current date. To the knowledge of the Responsible Shareholders, the
design and function of the Company's products and services ensure year 2000 A.D.
functionality and include, but are not limited to, date data century
recognition, calculations that accommodate same century and multi-century
formulas and date values, and date data interface values that reflect the
century. The Responsible Shareholders make no representations or warranties with
respect to whether or not the products or services of any supplier (including
licensors of software) to the Company are Year 2000 compliant or that the
performance of such products, or the provision of such services, will not be
interrupted by Year 2000 issues.
2.24 SCHEDULES. All Schedules attached hereto are true, correct and
complete in all material respects as of the date of this Agreement. Matters
disclosed on each Schedule shall be deemed disclosed only for purposes of the
matters to be disclosed in such Schedule and shall not be deemed to be disclosed
for any other purpose unless specifically provided therein.
-13-
<PAGE> 14
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF PURCHASER
Purchaser represents and warrants to the Shareholders as follows:
3.1 ORGANIZATION AND STANDING. Purchaser is a corporation duly
organized, validly existing and in good standing under the laws of the State of
Delaware with the full power and authority to carry on its business in the
places and as it is now being conducted.
3.2 AUTHORITY AND STATUS. Purchaser has the capacity and authority to
execute and deliver this Agreement, to perform under it and to consummate the
transactions contemplated by this Agreement without the necessity of any act or
consent of any other person whomsoever. This Agreement and each and every
agreement, document and instrument to be executed, delivered and performed by
Purchaser in connection with this Agreement constitute or will, when executed
and delivered, constitute the valid and legally binding obligations of
Purchaser, enforceable against Purchaser in accordance with their respective
terms, except as enforceability may be limited by applicable equitable
principles (whether applied with action at law or in equity) or by bankruptcy,
insolvency, reorganization, moratorium or similar laws from time to time in
effect affecting the enforcement of creditors' rights generally.
3.3 AGREEMENT DOES NOT VIOLATE OTHER INSTRUMENTS. Except as set forth
on SCHEDULE 3.3, the execution and delivery of the Transaction Documents by
Purchaser do not, and the consummation of the transactions contemplated hereby
will not, (a) violate or conflict with any provision of the Certificate of
Incorporation, as amended, or Bylaws, as amended, of Purchaser; (b) require any
consent or approval under, conflict with, result in the breach, termination or
acceleration of, or violate or constitute an occurrence of default under any
provision of any mortgage, deed of trust, conveyance to secure debt, note, loan,
lien, lease, agreement or instrument to which Purchaser is a party or by which
the Purchaser or any of its properties are bound; or (c) constitute a violation
of any law, regulation, order, writ, judgment, injunction, or decree applicable
to Purchaser or any of Purchaser's properties.
ARTICLE IV
COVENANTS AND UNDERTAKINGS
4.1 COVENANTS NOT TO COMPETE. At Closing, the Responsible Shareholders
will each enter into a Covenant Not to Compete with Purchaser and the Company
substantially in the form of attached EXHIBIT 4.1 (the "Covenants Not to
Compete").
4.2 EMPLOYMENT AGREEMENTS. At Closing, the Responsible Shareholders
shall each enter into an Employment Agreement with the Company in substantially
the form attached hereto as EXHIBIT 4.2 (each an "Employment Agreement").
-14-
<PAGE> 15
4.3 [INTENTIONALLY OMITTED.]
4.4 SHAREHOLDER CONSENT. Each Shareholder shall execute and deliver a
Shareholder Consent and Power of Attorney substantially in the form of attached
EXHIBIT 4.4 (the "Shareholder Consent") appointing French to act as his, her or
its attorney-in-fact for purposes of this Agreement and the obligations and
covenants of such Shareholder hereunder. In such capacity French (and any
successor of French in such capacity as provided in the Shareholder Consent) is
referred to in this Agreement as the "Shareholders' Representative."
4.5 CONSENTS AND APPROVALS. Each Responsible Shareholder agrees to use
his, her or its best efforts to obtain the waiver, consent and approval of all
persons whose waiver, consent or approval is required in order to consummate the
transactions contemplated by this Agreement, or is required by any agreement,
lease, instrument, arrangement, judgment, decree, order or license to which the
Company or any Shareholder is a party or subject that would prohibit, or require
the waiver, consent or approval of any person to such transactions, or under
which the consummation of such transactions would constitute (or with notice or
lapse of time would constitute) an event of default.
4.6 [INTENTIONALLY OMITTED.]
4.7 TERMINATION OF EMPLOYMENT AGREEMENTS. Each Responsible Shareholder
severally agrees that any (a) employment agreement which provides for (i) a set
or minimum term or employment, (ii) payment in lieu of notice of termination in
excess of thirty (30) days' pay, or (iii) required notice of termination of more
than thirty (30) days to which he, she or it is a party with the Company (other
than the Employment Agreements), or (b) management agreement, will be terminated
effective at the Closing without any further action by such Responsible
Shareholder, the Company or Purchaser, and no party to any such agreement will
have any liability or obligation thereunder of any nature or kind from and after
the Closing Date.
4.8 RESIGNATIONS. At the Closing, the Company will deliver to Purchaser
resignations, effective on or before the Closing Date of each officer and each
director resigning from all director and/or officer positions held by such
person with the Company.
ARTICLE V
CONDITIONS PRECEDENT TO OBLIGATIONS OF PURCHASER
The obligations of Purchaser to consummate the transactions
contemplated by this Agreement shall be subject to the satisfaction, on or
before the Closing Date, of each and every one of the following conditions:
5.1 REPRESENTATIONS TRUE AND COVENANTS PERFORMED AT CLOSING. The
representations and warranties made by the Shareholders in this Agreement or any
document or instrument delivered to Purchaser or its representatives hereunder
shall be true and correct on the Closing Date with the same force and effect as
if such representations and warranties had been
-15-
<PAGE> 16
made on and as of the Closing Date. Each Shareholder shall have duly performed
all of the agreements, covenants, acts and undertakings to be performed by such
Shareholder on or prior to the Closing Date.
5.2 NO INJUNCTION, ETC. No action, proceeding, investigation,
regulation or legislation shall have been instituted, threatened or proposed
before any court, governmental agency or legislative body to enjoin, restrain,
prohibit, or obtain substantial damages in respect of, or which is related to,
or arises out of, this Agreement or the consummation of the transactions
contemplated hereby, or which is related to or arises out of the business of the
Company, if such action, proceeding, investigation, regulation or legislation,
in the good faith judgment of Purchaser, would make it inadvisable to consummate
such transactions or would have a material adverse effect on the Company or its
assets or business.
5.3 NO MATERIAL ADVERSE CHANGE. There shall not have been any material
adverse change in the business, assets, liabilities or condition, financial or
otherwise, of the Company between the date of the Interim Financial Statements
and the Closing Date.
5.4 CONSENTS. The Shareholders shall have delivered to Purchaser the
written consents of third parties and all governmental consents and approvals,
if any, referred to in Section 4.5 hereof, which consents shall be in form,
scope and substance reasonably satisfactory to Purchaser and its counsel.
5.5 GOOD STANDING CERTIFICATE. Purchaser shall have received a
Certificate of Existence or Good Standing from the State of Texas, and from each
other state in which the Company is qualified to transact business as a foreign
corporation, with respect to the Company as of the most recent practical date
prior to the Closing Date.
5.6 DUE DILIGENCE. Purchaser shall in all respects be satisfied in
its discretion with the results of its due diligence investigation of the
Company and its assets and business.
5.7 OPINION OF COUNSEL. Purchaser shall have received an opinion of
counsel to the Shareholders substantially in the form of attached EXHIBIT 5.7.
ARTICLE VI
CONDITIONS PRECEDENT TO THE
OBLIGATIONS OF THE SHAREHOLDERS TO CLOSE
The obligations of the Shareholders to consummate the transactions
contemplated by this Agreement shall be subject to the satisfaction, on or
before the Closing Date, of each and every one of the following conditions:
6.1 REPRESENTATIONS TRUE AND COVENANTS PERFORMED AT CLOSING. The
representations and warranties made by Purchaser in this Agreement or any
document or
-16-
<PAGE> 17
instrument delivered to the Shareholders or their representatives hereunder
shall be true and correct on the Closing Date with the same force and effect as
though such representations and warranties had been made on and as of such date.
Purchaser shall have duly performed all of the agreements, covenants, acts and
undertakings to be performed by it on or prior to the Closing Date.
6.2 NO INJUNCTION, ETC. No action, proceeding, investigation,
regulation or legislation shall have been instituted, threatened or proposed
before any court, governmental agency or legislative body to enjoin, restrain,
prohibit, or obtain substantial damages in respect of, or which is related to,
or arises out of, this Agreement or the consummation of the transactions
contemplated hereby.
ARTICLE VII
CLOSING
7.1 TIME AND PLACE OF CLOSING. The closing (the "Closing") of the
transactions contemplated by this Agreement will be held on 25 June 1998 or such
other date as the parties may agree. The Closing shall commence at 10:00 a.m. at
the offices of Medirisk, Inc., Two Piedmont Center, Suite 400, 3565 Piedmont
Road, N.E., Atlanta, Georgia 30305-1502 or at such other time or place upon
which the parties agree. The date on which Closing occurs shall be referred to
as the "Closing Date."
7.2 TRANSACTIONS AT CLOSING. At the Closing:
(A) Each of the Shareholders shall deliver to Purchaser
certificates for the Company Stock sold by such Shareholder to Purchaser, duly
endorsed for transfer or accompanied by blank stock powers;
(B) The Responsible Shareholders shall deliver or cause to be
delivered to Purchaser Certificates of Good Standing of the Company, as of the
most recent practicable date, as contemplated by Section 5.5;
(C) As contemplated by Section 4.1, Purchaser, the Company and
each of the Responsible Shareholders shall execute and deliver to each other the
Covenants Not to Compete;
(D) As contemplated by Section 4.2, the Company and each of
the Responsible Shareholders shall execute and deliver to each other the
Employment Agreements;
(E) As contemplated by Section 4.4, each of the Shareholders
shall execute and deliver to Purchaser a Shareholder Consent;
(F) Counsel for the Shareholders shall have delivered to
Purchaser the form of opinion attached hereto as Exhibit 5.7; and
-17-
<PAGE> 18
(G) Purchaser shall disburse the Purchase Consideration as set
forth in SCHEDULE 1.2 (that portion thereof deliverable to the Shareholders who
have tendered their certificates representing Company Stock to be allocated
among such Shareholders as set forth on SCHEDULE 1.2 under the heading
"Allocation of Purchase Consideration Among Shareholders").
ARTICLE VIII
SURVIVAL OF REPRESENTATIONS AND WARRANTIES AND INDEMNIFICATION
The parties shall have the mutual rights of indemnification set forth
in Schedule 8 attached hereto.
ARTICLE IX
[INTENTIONALLY OMITTED.]
ARTICLE X
GENERAL PROVISIONS
10.1 NOTICES.
(A) All notices, requests, demands and other communications
hereunder shall be in writing and shall be delivered by hand, facsimile or
mailed by nationally recognized overnight delivery service or by registered or
certified mail, return receipt requested, first class postage prepaid, addressed
as follows:
IF TO ANY SHAREHOLDER:
Robert P. French, Shareholders' Representative
4601 Huffman Court
Plano, Texas 75093
Facsimile: (972) 620-5787
-18-
<PAGE> 19
With a copy (which shall not constitute notice) to:
Homer B. Reynolds, III, Esq.
Law Offices of Homer B. Reynolds, III PC
NationsBank Tower, Suite 1021
101 East Park Boulevard
Plano, Texas 75074
Facsimile: (972) 578-1262
IF TO PURCHASER:
Medirisk, Inc.
Two Piedmont Center, Suite 400
3565 Piedmont Road
Atlanta, Georgia 30305-1502
Attention: Legal Department
Facsimile: (404) 364-6703
(B) If delivered personally or by facsimile, the date on which
a notice, request, instruction or document is delivered shall be the date on
which such delivery is made and, if delivered by mail, the date on which such
notice, request, instruction or document is received shall be the date of
delivery.
(C) Any party hereto may change its address specified for
notices herein by designating a new address by notice in accordance with this
Section 10.1.
10.2 BROKERS. Purchaser represents and warrants to the Shareholders,
and the Responsible Shareholders jointly and severally, and VHA severally,
represent and warrant to Purchaser, that, except as disclosed in SCHEDULE 10.2,
no broker or finder has acted for it or them or any entity controlling,
controlled by or under common control with it or them in connection with this
Agreement.
10.3 FURTHER ASSURANCES. Each party covenants that at any time, and
from time to time, after the Closing, it will execute such additional
instruments and take such actions as may be reasonably requested by the other
parties to confirm or perfect or otherwise to carry out the intent and purposes
of this Agreement.
10.4 WAIVER. Any failure on the part of any party hereto to comply with
any of its obligations, agreements or conditions hereunder may be waived by any
other party to whom such compliance is owed. No waiver of any provision of this
Agreement shall be deemed, or shall
-19-
<PAGE> 20
constitute, a waiver of any other provision, whether or not similar, nor shall
any waiver constitute a continuing waiver.
10.5 EXPENSES. All expenses incurred by the parties hereto in
connection with or related to the authorization, preparation and execution of
this Agreement and the Closing of the transactions contemplated hereby,
including, without limitation of the generality of the foregoing, all fees and
expenses of agents, representatives, counsel and accountants employed by any
such party, shall be borne solely and entirely by the party which has incurred
the same. The Shareholders agree that the Company shall not pay any expenses in
connection with or related to the authorization, preparation and execution of
this Agreement or the Closing of the transactions contemplated hereby (all such
expenses to be paid by the Shareholders from the Purchase Consideration
according to their proportionate interests in the Company) and that, if the
Company pays any such expenses, Shareholders shall promptly reimburse the
Company for any amount so paid.
10.6 BINDING EFFECT. This Agreement shall be binding upon and inure to
the benefit of the parties hereto and their respective heirs, legal
representatives, executors, administrators, successors and assigns.
10.7 HEADINGS. The section and other headings in this Agreement are
inserted solely as a matter of convenience and for reference, and are not a part
of this Agreement.
10.8 ENTIRE AGREEMENT. This Agreement constitutes the entire agreement
among the parties hereto and supersedes and cancels any prior agreements,
representations, warranties, or communications, whether oral or written, among
the parties hereto relating to the transactions contemplated hereby or the
subject matter herein. Neither this Agreement nor any provision hereof may be
changed, waived, discharged or terminated orally, but only by an agreement in
writing signed by the party against whom or which the enforcement of such
change, waiver, discharge or termination is sought.
10.9 GOVERNING LAW. This Agreement shall be governed by and
construed in accordance with the laws of the State of Texas.
10.10 COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.
10.11 PRONOUNS. All pronouns used herein shall be deemed to refer to
the masculine, feminine or neuter gender as the context requires.
10.12 ARBITRATION. The parties hereto will attempt to resolve any
controversy, claim or dispute arising under this Agreement promptly by
negotiations between the parties. If any party reaches the conclusion that the
controversy, claim or dispute cannot be resolved by unassisted negotiations,
such party may request that such controversy, claim or dispute be settled by
binding arbitration administered by the American Arbitration Association in
accordance with
-20-
<PAGE> 21
its commercial arbitration rules and procedures, as in effect on the date of the
commencement of arbitration proceedings. The arbitral tribunal shall consist of
three members, with the claimant and respondent each appointing one arbitrator,
and with the party-appointed arbitrators appointing the third, neutral
arbitrator. The arbitrators selected pursuant to this provision shall be
qualified by training, education, and experience to rule on the issues
presented, and the chairperson of the tribunal shall be a lawyer experienced in
the litigation of business disputes. The arbitration shall be held in Chicago,
Illinois. The award shall be in writing and shall state the reasoning on which
the award rests. A judgment on the award may be entered in any court of
competent jurisdiction. The parties further agree that if a dispute is submitted
to arbitration, the prevailing party shall be entitled to recover from the
non-prevailing party the reasonable attorneys' fees incurred by the prevailing
party in connection with the matter which is the subject of such proceeding.
-21-
<PAGE> 22
IN WITNESS WHEREOF, each party hereto has executed or caused this
Agreement to be executed on its behalf, all on the day and year first above
written.
PURCHASER:
MEDIRISK, INC.
By:
---------------------------------
Kenneth M. Goins, Jr.
Executive Vice President &
Chief Financial Officer
SHAREHOLDERS:
------------------------------------
MARSHA L. BALLARD
------------------------------------
ROBERT P. FRENCH
VHA SOUTHWEST, INC.
By:
------------------------------
Name:
------------------------------
Title:
------------------------------
<PAGE> 1
MEDIRISK(SM)
NEWS RELEASE
Contact: Mark A. Kaiser
Chairman and CEO
(404) 364-6700
MEDIRISK EXPECTS SECOND QUARTER SHORTFALL
-----------------
ACQUIRES SWEETWATER HEALTH ENTERPRISES FOR $6.2 MILLION
-----------------
EXPANDS CREDIT LINE TO $25 MILLION
ATLANTA, Georgia (June 30, 1998) Medirisk, Inc. (Nasdaq/NM:MDMD), a leading
provider of proprietary database products, decision-support software and
analytical services to the healthcare industry, today announced that second
quarter revenues and adjusted earnings per share will be lower than expected.
The Company also announced the acquisition of Sweetwater Health Enterprises,
Inc., a healthcare information company that provides physician credentialing
services, quality management software and managed care consulting services to
healthcare payors and providers. Additionally, Medirisk announced that its
line of credit with NationsBank, N.A. has been increased to $25 million.
Second Quarter Outlook
Based on a preliminary analysis of results for the second quarter
ending June 30, 1998, revenues are expected to be in the range of $5.1 million
to $5.3 million and earnings per share, adjusted to exclude one-time,
non-recurring charges, are expected to be in the range of breakeven to earnings
of $0.02 per share; however, no assurance can be given as to actual results.
The Company reported revenues of $3.2 million and adjusted earnings per share
of $0.07 per share in the second quarter of 1997.
Mark A. Kaiser, chairman and chief executive officer, stated, "We
expect results for the quarter to be lower than anticipated due to softness in
our Market Performance Products, specifically the financial products, and to a
lesser degree in our Physician Credentials Products, specifically credentialing
services. In the Market Performance Product area, we are taking action to
change sales management, implement new product distribution channels and
introduce new product enhancements. With Physician Credentials, our
acquisition of Sweetwater is expected to provide opportunities through volume,
capacity and operational synergies to leverage our 1997 acquisition of CIVS.
With the acquisition of Sweetwater, we are now one of the largest providers of
credentialing services and information in the U.S. While we are disappointed
with the current results, we believe the actions we have taken will have a
meaningful impact. However, the softness in these particular areas is expected
to carry over into the second half of the year."
-MORE-
<PAGE> 2
Medirisk Acquires Sweetwater Health Enterprises
Page 2
June 30, 1998
The Company does not expect to make any further announcements
concerning the second quarter results until definitive numbers are available.
The Company anticipates reporting second quarter results the week of July 13,
1998.
Sweetwater Health Enterprises, Inc. Acquisition
Medirisk purchased Sweetwater for approximately $6.2 million in cash.
Medirisk expects to record a non-recurring charge of approximately $4.25
million in the second quarter of 1998 relating to the acquisition of in-process
research and development and approximately $800,000 during 1998 for planned
integration costs. Medirisk will account for the acquisition of Sweetwater as a
purchase transaction. This transaction marks Medirisk's ninth acquisition
since January 1996, and the seventh acquisition since its 1997 initial public
offering.
Sweetwater offers a comprehensive selection of physician credentialing
services to hospitals and managed care organizations to evaluate professional
relationships with physicians and secure accreditation by industry
associations. In addition, Sweetwater provides a suite of quality management
software used by healthcare organizations to facilitate in-house credentialing
and network management, as well as to track perceptions of care and individual
physician performance. Sweetwater also provides managed care consultation and
interim management services for health-care organizations throughout the
country.
Commenting on the acquisition, Mr. Kaiser stated, "Sweetwater's
credentialing software, combined with our existing credentialing products,
significantly enhances our ability to meet both the outsourcing and in-house
physician credentialing needs of healthcare organizations. With Sweetwater's
customer base predominantly in the Midwest and on the West Coast, there is no
significant overlap with our existing physician credentialing and verifications
customer base. Sweetwater's consulting practice presents a unique opportunity
to provide additional value in the delivery of Medirisk's information products.
"Recent acquisitions such as Sweetwater, Successful Solutions and
Healthdemographics, as well as acquisitions completed in 1997, continue to
exhibit our ability to expand into complementary product areas and increase
market share within existing product lines. With these three acquisitions in
the first half of 1998 alone, we have strengthened our physician credentials
offerings, added the ability to forecast the supply and demand for health care
and added a consulting capability."
-MORE-
<PAGE> 3
Medirisk Acquires Sweetwater Health Enterprises
Page 3
June 30, 1998
Marsha Ballard, president of Sweetwater, stated, "This alliance with
Medirisk is an exciting opportunity for Sweetwater and its customers to gain
access to a compelling selection of information products and services. We are
delighted to join the dynamic Medirisk team."
On June 29, 1998, the Company and NationsBank, N.A. entered into an
Amended and Restated Credit Agreement under which the maximum amount available
under the Company's revolving line of credit was increased from $10.0 million
to $25.0 million. In addition to the increase in availability, the Amended and
Restated Credit Agreement also extends the maturity of the credit facility to
July 15, 2000 and lowers the interest rates payable on LIBOR borrowings.
Medirisk, Inc. is a leading provider of proprietary database products,
decision-support software and analytical services to the healthcare industry.
The Company's products and services enable its customers to make objective
comparisons of the financial costs and clinical outcomes of physician services
to customer-specific and industry benchmarks, analyze the supply of and demand
for healthcare services, assess patient satisfaction with specific managed care
plans and obtain information concerning the background and credentials of
physicians. These capabilities assist healthcare industry participants in
strategic planning, effective contracting and improving the delivery of care.
Medirisk's corporate headquarters are located in Atlanta, Georgia.
This press release, particularly the statements by Mr. Kaiser and Ms.
Ballard, includes forward-looking statements related to Medirisk that involve
risks and uncertainties including, but not limited to, quarterly fluctuations
in results, the management of growth, market acceptance of certain products and
other risks. These forward-looking statements are made in reliance on the "safe
harbor" provisions of the Private Securities Litigation Reform Act of 1995. For
further information about these factors that could affect Medirisk's future
results, please see the Company's recently filed Form S-3, as amended
(Registration Number 333-50015) and its other filings with the Securities and
Exchange Commission. Prospective investors are cautioned that forward- looking
statements are not guarantees of future performance Actual results may differ
materially from management expectations. Copies of the filings are available
upon request from Medirisk's investor relations department.
-END-
